Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Alcon AG(ALC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for ALC
10/23/2026: ALC (1-star) is currently NOT-A-BUY. Pass it for now.
Alcon AG is a global pure-play medical device company focused exclusively on eye care. The company holds a leading position in cataract surgery equipment and vision correction products, benefiting from long-term demographic shifts and recurring revenue streams. Its main growth opportunity lies in expanding its premium product portfolio and increasing penetration in emerging markets. Investors should monitor competitive pressures from other medical device makers and potential regulatory shifts in healthcare reimbursement that could impact procedure volumes. Alcon is generally well-suited for investors seeking exposure to a stable, high-margin healthcare franchise, though valuation premiums should be carefully considered given the company's reliance on successful product innovation.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Alcon offers steady growth prospects driven by global demographic trends in eye health. |
| Momentum investor | Mixed fit | The stock is currently a stable performer; momentum depends on positive quarterly beats. |
| Value investor | Mixed fit | Alcon often trades at a premium valuation due to its high-quality market position. |
| Dividend investor | Mixed fit | Alcon pays a dividend, but it is primarily a growth-oriented medical device company. |
| Low-risk investor | Strong fit | The essential nature of eye care provides relative stability in varying market cycles. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | General market fluctuations can impact the share price despite fundamental strength. |
| Valuation risk | Medium / high | A premium price tag requires consistent growth to justify current trading levels. |
| Competition risk (Ophthalmic device rivalry) | High | Aggressive R&D from peers threatens Alcon's market-leading positions. |
| Business quality | Strong | Alcon is a dominant, specialized franchise in a necessary healthcare sector. |
| Dividend income | Low | Dividends are not the primary reason to hold this stock. |
| Execution risk | Medium | Successfully managing large R&D pipelines and global supply chains is essential. |
Price Behavior
Downtrend
The stock has experienced a sustained decline in price over recent periods.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -28.56% | Avg. Invested days 36 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/23/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 33.92B USD | Price to earnings Ratio 53.16 | 1Y Target Price 82.73 |
Price to earnings Ratio 53.16 | 1Y Target Price 82.73 | ||
Volume (30-day avg) 1.8M shares | Beta 0.73 | 52 Weeks Range 61.84 - 87.22 | Updated Date 10/25/2026 |
52 Weeks Range 61.84 - 87.22 | Updated Date 10/25/2026 | ||
Dividends yield (FY) 0.51% | Basic EPS (TTM) 1.32 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Surgical | Cataract equipment, IOLs, and surgical consumables. | Alcon makes significant money by selling both the machines used in surgeries and the recurring supplies needed for each procedure. |
| Vision Care | Contact lenses and eye care solutions. | This is a high-volume, recurring consumer business that drives consistent revenue growth. |
| Geography | Global sales across North America, EMEA, and APAC. | A diversified global footprint helps balance regional economic risks. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 53.16 | Forward PE 16.92 | Enterprise Value 36.39B | Price to Sales(TTM) 3.12 |
Enterprise Value 36.39B | Price to Sales(TTM) 3.12 | ||
Enterprise Value to Revenue 3.35 | Enterprise Value to EBITDA 13.34 | Shares Outstanding 483.40M | Shares Floating 481.83M |
Shares Outstanding 483.40M | Shares Floating 481.83M | ||
Percent Insiders 0.2 | Percent Institutions 63.1 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.